Anti-tumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo

被引：0
|
作者：
Ray, J. [1 ]
Ralff, M. [1 ]
Jhaveri, A. [2 ]
El-Deiry, W. [2 ]
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.06.158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
85
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] Anti-tumorigenic effect of ONC201 is enhanced by combination treatment with TRAIL or a DR5 agonist in endometrial cancer in vitro
    Ray, Jocelyn
    Raiff, Marie
    Dicker, David
    Ei-Deiry, Wafik
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo
    Ray, Jocelyn E.
    Ralff, Marie D.
    Jhaveri, Aakash
    Zhou, Lanlan
    Dicker, David T.
    Ross, Eric A.
    El-Deiry, Wafik S.
    CANCER BIOLOGY & THERAPY, 2021, 22 (10-12) : 554 - 563
  • [3] ONC201 has anti-tumorigenic effects in obesity-driven endometrial cancer
    Tucker, K.
    Staley, A.
    Pierce, S. R.
    Fan, Y.
    Yin, Y.
    Sun, W.
    Zhao, X.
    Zhang, Y.
    Lee, D.
    Prabhu, V.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 49 - 49
  • [4] ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro
    Fang, Ziwei
    Wang, Jiandong
    Clark, Leslie H.
    Sun, Wenchuan
    Yin, Yajie
    Kong, Weimin
    Pierce, Stuart R.
    West, Lindsay
    Sullivan, Stephanie A.
    Tran, Arthur-Quan
    Prabhu, Varun V.
    Zhou, Chunxiao
    Bae-Jump, Victoria
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (08): : 1551 - 1563
  • [5] ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer
    Hawkins, G. M.
    Fan, Y.
    Fang, Z.
    Huang, Y.
    Sun, W.
    Paraghamian, S. E.
    Yin, Y.
    Prabhu, V. V.
    Allen, J. E.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 28 - 29
  • [6] Effect of combination of ONC201 and bevacizumab on colorectal cancer (CRC) growth and metastasis in vivo
    Ei-Deiry, Wafik S.
    Wagner, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Combination ONC201 and radiation therapy in the treatment of breast cancer
    Jhawar, Sachin R.
    Schiff, Devora
    Wu, Hao
    Thandoni, Aditya
    Hassan, Suemair
    Allen, Joshua
    Stogniew, Martin
    Tarapore, Rohinton
    Oster, Wolfgang
    Stein, Mark
    Silk, Ann W.
    Goyal, Sharad
    Haffty, Bruce G.
    Zloza, Andrew
    CANCER RESEARCH, 2018, 78 (13)
  • [8] The dopamine receptor D2 antagonist ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer
    Staley, Allison
    Tucker, Katherine
    Fang, Ziwei
    Fan, Yali
    Sun, Wenchuan
    Yin, Yajie
    Zhang, Yingao
    Prabhu, Varun
    Zhou, Chunxiao
    Bae-Jump, Victoria
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Ipatasertib exhibits anti-tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo
    O'donnell, Jillian
    Zhao, Ziyi
    Buckingham, Lindsey
    Hao, Tianran
    Suo, Hongyan
    Zhang, Xin
    Fan, Yali
    John, Catherine
    Deng, Boer
    Shen, Xiaochang
    Sun, Wenchuan
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria L. L.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (03)
  • [10] Combination of ONC201 and bevacizumab significantly impacts colorectal cancer growth and metastasis in vivo
    Wagner, Jessica
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2016, 76
12345